Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

This study has been completed.
Sponsor:
Information provided by:
Abbott
ClinicalTrials.gov Identifier:
NCT00061672
First received: June 2, 2003
Last updated: August 13, 2007
Last verified: August 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given